J. Moore

发表

The Cellular Mechanisms of Tumor Necrosis Factor-Induced Mortality: A Possible Role for Platelet Activating Factor and/or the Eicosanoids

N. Abumrad, J. Moore, M. Hubbard, 1993 .

Practical applications of time-averaged restrained molecular dynamics to ligand-receptor systems: FK506 bound to the Q50R,A95H,K98I triple mutant of FKBP-13

D. Pearlman, J. Moore, D. Livingston, 1996, Journal of biomolecular NMR.

Selection of T-DNA-tagged male and female gametophytic mutants by segregation distortion in Arabidopsis.

U. Grossniklaus, J. Moore, D. Twell, 1998, Genetics.

Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid.

Mingyan Zhu, R. Natarajan, J. Nadler, 2000, Journal of neurophysiology.

Angiotensin II type 1 receptor-mediated inhibition of K+ channel subunit kv2.2 in brain stem and hypothalamic neurons.

J. Moore, C. Sumners, B. Horowitz, 1999, Circulation research.

NMR screening in drug discovery.

J. Moore, J M Moore, 1999, Current opinion in biotechnology.

High-resolution solution structure of reduced French bean plastocyanin and comparison with the crystal structure of poplar plastocyanin.

D. Case, G. Gippert, P. Wright, 1991, Journal of molecular biology.

Three-dimensional solution structure of plastocyanin from the green alga Scenedesmus obliquus.

Timothy F. Havel, D. Case, G. Gippert, 1988, Science.

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery.

Ajay, G. Bemis, M. Murcko, 1999, Chemistry & biology.

31P NMR studies of enzyme-bound substrate complexes of yeast 3-phosphoglycerate kinase: III. Two ADP binding sites and their Mg(II) affinity; effects of vanadate and arsenate on enzymic complexes with ADP and 3-P-glycerate.

J. Moore, B. Rao, B. D. Ray, 1990, Journal of inorganic biochemistry.

A cloned cDNA probe for rat immunoglobulin epsilon heavy chain: construction, identification, and DNA sequence.

E. Reddy, W. Kindsvogel, J. Moore, 1982, DNA.

15N NMR relaxation studies of the FK506 binding protein: backbone dynamics of the uncomplexed receptor.

J. Fulghum, J. Moore, S. P. Chambers, 1993, Biochemistry.

Murine myeloma immunoglobulin heavy-chain mRNA. Isolation, partial purification, and characterization of gamma1, gamma2a, gamma2b, gamma3, micron and alpha heavy-chain mRNA'S.

J. Moore, C. Faust, I. Heim, 1979, Biochemistry.

NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.

J. Moore, Jonathan M. Moore, 1999, Biopolymers.

Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12.

D. Pearlman, J. Moore, D. Livingston, 1994, Biochemistry.

Negative Transcriptional Regulation Mediated by Thyroid Hormone Response Element 144 Requires Binding of the Multivalent Factor CTCF to a Novel Target DNA Sequence*

P. Neiman, Victor V Lobanenkov, G. Filippova, 1999, The Journal of Biological Chemistry.

LAF1, a MYB transcription activator for phytochrome A signaling.

U. Grossniklaus, N. Chua, J. Moore, 2001, Genes & development.

15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition.

J. Moore, C. Lepre, J. W. Cheng, 1994, Biochemistry.

Kinetics and thermodynamics of dimer formation and dissociation for a recombinant humanized monoclonal antibody to vascular endothelial growth factor.

M. Cromwell, J. Moore, T. Patapoff, 1999, Biochemistry.

Identification of key residues involved in adrenomedullin binding to the AM1 receptor

J. Archbold, M. Brimble, J. Moore, 2013, British journal of pharmacology.

Coordination scheme and stereochemical configuration of manganese(II) adenosine 5'-diphosphate at the active site of 3-phosphoglycerate kinase.

G. H. Reed, J. Moore, 1985, Biochemistry.

1H NMR studies of plastocyanin from Scenedesmus obliquus: complete sequence-specific assignment, secondary structure analysis, and global fold.

P. Wright, W. Chazin, J. Moore, 1988, Biochemistry.

Nuclear magnetic resonance-based approaches for lead generation in drug discovery.

J. Peng, J. Moore, N. Abdul-Manan, 2001, Methods in enzymology.

A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.

J. Moore, M. Earnest, A. Disimone, 1991, Circulatory shock.